Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - AI and Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Technology
May 23, 2016 12:00 AM

Former Warner Chilcott president's trial may signal further executive crackdown

Lisa Schencker
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    (Story updated at 5:27 p.m. ET)

    The trial of a former Warner Chilcott president may be among the first of more to come for healthcare executives as the U.S. Justice Department increasingly holds individuals accountable for corporate wrongdoing.

    Former Warner Chilcott President W. Carl Reichel was arrested in October and charged with conspiring with members of the drug company's sales force to pay kickbacks to doctors in exchange for writing prescriptions. He allegedly encouraged members of the sales force to take doctors out to so-called medical education dinners that were actually social events, and pay doctors to speak at those events so long as they prescribed the company's products.

    An attorney for Reichel declined to comment Monday. But his attorneys have argued in court documents that there's no direct evidence that Reichel ever gave his sales people such direction, and that they may have misinterpreted his actual instructions.

    His trial was scheduled to begin Monday in federal court in Boston. As a company, Warner Chilcott agreed in October to plead guilty to healthcare fraud and pay the government $125 million to resolve civil and criminal allegations.

    Many say the case against Reichel is evidence of the Justice Department's recent pledge to hold accountable more executives tangled in fraud allegations.

    Fraud fighters have long complained that the Justice Department too often lets corporate executives off the hook and that only by holding individuals accountable will the government be able to truly deter fraud.

    Last September, U.S. Deputy Attorney Sally Quillian Yates penned a memo emphasizing the importance of accountability in cases of corporate corruption. In that memo, Yates said that companies must now disclose “all relevant facts relating to the individuals responsible for the misconduct” in order to qualify for “cooperation credit”—less severe penalties in exchange for cooperating with the Justice Department.

    Since that memo, the Justice Department has more closely scrutinized individuals in both civil and criminal cases, such as the one against Reichel, said Marc Raspanti, a partner at Pietragallo Gordon Alfano Bosick & Raspanti who represents whistle-blowers and is a former government prosecutor.

    Raspanti said he knows of “many, many individuals” the department is now investigating, though their names have not yet been released publicly.

    Following that Yates memo, Department prosecutors now have to formally indicate whether they will or will not pursue individuals in cases of corporate misconduct, said Bill Jordan, a partner at Alston & Bird and a former senior official at the Department of Justice.

    Because of that, "you're going to see a lot more" of these cases, Jordan said. “I do think it's a trend that's only going to increase over the next few years.”

    Gabriel Imperato, a managing partner at Broad and Cassel who represents healthcare companies, said the Justice Department's pursuit of a criminal case against an executive such as Reichel isn't new. He said the department would likely have charged Reichel with or without the Yates memo.

    But he said the department's attitude toward individuals involved in allegations of corporate wrongdoing on the civil side has definitely shifted.

    In the past, for example, attorneys could often get the department to release individuals involved from liability. The department isn't keen on that anymore, he said. Imperato said the department refused his request in a recently settled a small False Claims Act case.

    “There is some anecdotal evidence that executives, I think, are taking notice, paying more attention to compliance,” Imperato said.

    Reichel is not the only executive facing trial over allegations of corporate wrongdoing.

    William Facteau and Patrick Fabian, former CEO and vice president of sales at medical device company Acclarent, are also scheduled to stand trial June 6 in federal court in Boston. The two were indicted last year on one count of conspiracy, three counts of securities fraud, four counts of wire fraud and 10 counts of introducing adulterated or misbranded medical devices into interstate commerce.

    They allegedly fraudulently drove up Acclarent revenues and stock valuation by illegally marketing a medical device known as the Relieva Stratus Microflow Spacer for uses not cleared or approved by the Food and Drug Administration, according to the Justice Department. The device was meant to maintain an opening to a patient's sinus, but was allegedly marketed as a steroid delivery device despite the FDA's refusal to approve it for that purpose.

    Facteau and Fabian allegedly hid the company's illegal promotion and distribution of the device from Ethicon, a subsidiary of Johnson & Johnson, which purchased Acclarent in 2010.

    Attempts to reach attorneys for Facteau and Fabian were not immediately successful Monday, but their attorneys have said in court documents all counts of the indictment should be dismissed.

    Other executives who've been held accountable in the past include three from Pharma Purdue, formerly known as Purdue Frederick. In 2012, a federal appeals court ruled they could be excluded from doing business with the federal government after they pleaded guilty to failing to prevent the company's fraudulent marketing of the pain medication OxyContin.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    doctor_patient_tablet_getty_i_i.jpg
    How AI may influence pain medication prescriptions
    Amir Dan Rubin
    Amazon's One Medical CEO to step down later this year
    Most Popular
    1
    CMS tries luring providers to revamped Medicare ACOs
    2
    Oregon joins other states in setting ratios for nurse staffing
    3
    Blue Shield CA taps Amazon, Mark Cuban, CVS for new PBM model
    4
    A health innovation hub grows in Lake Nona Medical City
    5
    Hospital-at-home providers push for Medicaid coverage
    Sponsored Content
    Digital Health Intelligence Newsletter: Sign up to receive a twice-weekly (T, F) morning newsletter featuring the latest reporting on technologies, trends, players and money fueling the rapid changes in how healthcare is developed, paid for and delivered.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - AI and Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing